Your cart Items: 0
  • Contact Us For Prices from India

  • For order Just Make A Request

  • Exporters Of Generic Medicines

Buy Generic Alimta (Pemetrexed) Pemnat Online

Buy Generic Alimta (Pemetrexed) Pemnat

This announcement is made on the conference ASCO 2005 which presents the latest data on the role of gemcitabine (Gemzar) chemotherapy in a number of malignant tumors and the clinical efficacy of the drug from the group of antifolates - Pemetrexed (Alimta). Both drugs were developed and registered in the Russian company Eli Lilly.

product image

Generic Alimta

(Vial / 1 / 500mg)
Manufacturing: Natco
Indian brand: PEMNAT
Shipping time: 7 - 14 days

Add to Cart

The mechanism of antitumor action of pemetrexed due to inhibition of the synthesis of purines and pyrimidines. Adverse reactions include neutropenia, mucositis, and rash. Hematologic toxicity is significantly reduced when using folate and vitamin B12. Corticosteroids significantly reduce the occurrence of skin toxicity. There are currently installed anti-tumor activity of the drug in malignant mesothelioma, non-small cell lung cancer, pancreatic cancer, and others.

Nucleoside analogue gemcitabine is widely used in clinical practice as part of the standard modes in pancreatic cancer, small cell lung cancer, bladder cancer.

Breast cancer (BC) - a disease in which gemcitabine is actively studied as one of the basic drugs. Continue to search for the optimal variant of breast cancer chemotherapy 2nd line. The results comparing the combination of gemcitabine 1000 mg / m2 1 and 8 days and docetaxel 75 mg / m2 day 1 (150 patients), the most effective regimen 2nd line - Capecitabine 2500 mg / m2 1-14 day and docetaxel 75 mg / m2 day 1 (145 patients), every 3 weeks.

An objective effect was almost identical in both groups 27 and 31%, respectively. Hematological toxicity Grade III-IV were equally often, but often febrile neutropenia was observed with the combination of capecitabine plus docetaxel (12 vs. 7%). In addition, when using the circuit capecitabine plus docetaxel often develop diarrhea (17 versus 7%), mucositis (16 vs. 4%), and hand-foot syndrome (24% vs. 0). Based on preliminary data, the mode of gemcitabine plus docetaxel may be a worthy competitor to a recognized standard 2nd-line treatment of breast cancer.

• AntiCancer Group Medication